193 related articles for article (PubMed ID: 21677138)
1. Early and transient release of leukocyte pentraxin 3 during acute myocardial infarction.
Maugeri N; Rovere-Querini P; Slavich M; Coppi G; Doni A; Bottazzi B; Garlanda C; Cianflone D; Maseri A; Mantovani A; Manfredi AA
J Immunol; 2011 Jul; 187(2):970-9. PubMed ID: 21677138
[TBL] [Abstract][Full Text] [Related]
2. An intense and short-lasting burst of neutrophil activation differentiates early acute myocardial infarction from systemic inflammatory syndromes.
Maugeri N; Rovere-Querini P; Evangelista V; Godino C; Demetrio M; Baldini M; Figini F; Coppi G; Slavich M; Camera M; Bartorelli A; Marenzi G; Campana L; Baldissera E; Sabbadini MG; Cianflone D; Tremoli E; D'Angelo A; Manfredi AA; Maseri A
PLoS One; 2012; 7(6):e39484. PubMed ID: 22761804
[TBL] [Abstract][Full Text] [Related]
3. Cardioprotective function of the long pentraxin PTX3 in acute myocardial infarction.
Salio M; Chimenti S; De Angelis N; Molla F; Maina V; Nebuloni M; Pasqualini F; Latini R; Garlanda C; Mantovani A
Circulation; 2008 Feb; 117(8):1055-64. PubMed ID: 18268142
[TBL] [Abstract][Full Text] [Related]
4. Neutrophil-dependent pentraxin-3 and reactive oxygen species production modulate endothelial dysfunction in haemodialysis patients.
dell'Oglio MP; Simone S; Ciccone M; Corciulo R; Gesualdo M; Zito A; Cortese F; Castellano G; Gigante M; Gesualdo L; Grandaliano G; Pertosa GB
Nephrol Dial Transplant; 2017 Sep; 32(9):1540-1549. PubMed ID: 27915246
[TBL] [Abstract][Full Text] [Related]
5. Long pentraxin 3 (PTX3) expression and release by neutrophils in vitro and in ulcerative colitis.
Savchenko AS; Inoue A; Ohashi R; Jiang S; Hasegawa G; Tanaka T; Hamakubo T; Kodama T; Aoyagi Y; Ushiki T; Naito M
Pathol Int; 2011 May; 61(5):290-7. PubMed ID: 21501295
[TBL] [Abstract][Full Text] [Related]
6. Circulating monocyte-platelet aggregates are a more sensitive marker of in vivo platelet activation than platelet surface P-selectin: studies in baboons, human coronary intervention, and human acute myocardial infarction.
Michelson AD; Barnard MR; Krueger LA; Valeri CR; Furman MI
Circulation; 2001 Sep; 104(13):1533-7. PubMed ID: 11571248
[TBL] [Abstract][Full Text] [Related]
7. Source of Circulating Pentraxin 3 in Septic Shock Patients.
Albert Vega C; Mommert M; Boccard M; Rimmelé T; Venet F; Pachot A; Leray V; Monneret G; Delwarde B; Brengel-Pesce K; Mallet F; Trouillet-Assant S
Front Immunol; 2018; 9():3048. PubMed ID: 30687307
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of pentraxin 3 in neutrophils.
Razvina O; Jiang S; Matsubara K; Ohashi R; Hasegawa G; Aoyama T; Daigo K; Kodama T; Hamakubo T; Naito M
Exp Mol Pathol; 2015 Feb; 98(1):33-40. PubMed ID: 25449330
[TBL] [Abstract][Full Text] [Related]
9. Long pentraxin PTX3 attenuates ischemia reperfusion injury in a cardiac transplantation model.
Zhu H; Cui D; Liu K; Wang L; Huang L; Li J
Transpl Int; 2014 Jan; 27(1):87-95. PubMed ID: 24112130
[TBL] [Abstract][Full Text] [Related]
10. Expression of pentraxin 3 (PTX3) in human atherosclerotic lesions.
Savchenko A; Imamura M; Ohashi R; Jiang S; Kawasaki T; Hasegawa G; Emura I; Iwanari H; Sagara M; Tanaka T; Hamakubo T; Kodama T; Naito M
J Pathol; 2008 May; 215(1):48-55. PubMed ID: 18220316
[TBL] [Abstract][Full Text] [Related]
11. Pentraxin 3, long expression in mononuclear cells of patients with acute coronary syndrome: Correlation with C-reactive protein and matrix metalloproteinase-9 levels.
Ma R; Zhang W; Wang T; He X; Huang Z; Zhu J; Yao Z
J Int Med Res; 2014 Jun; 42(3):677-83. PubMed ID: 24709882
[TBL] [Abstract][Full Text] [Related]
12. The prototypic tissue pentraxin PTX3, in contrast to the short pentraxin serum amyloid P, inhibits phagocytosis of late apoptotic neutrophils by macrophages.
van Rossum AP; Fazzini F; Limburg PC; Manfredi AA; Rovere-Querini P; Mantovani A; Kallenberg CG
Arthritis Rheum; 2004 Aug; 50(8):2667-74. PubMed ID: 15334483
[TBL] [Abstract][Full Text] [Related]
13. Lipopolysaccharide induced expression of pentraxin 3 in human neutrophils and monocyte-derived macrophages.
Imamura M; Kawasaki T; Savchenko AS; Ohashi R; Jiang S; Miyamoto K; Ito Y; Iwanari H; Sagara M; Tanaka T; Hamakubo T; Kodama T; Uchiyama M; Naito M
Cell Immunol; 2007 Aug; 248(2):86-94. PubMed ID: 18045580
[TBL] [Abstract][Full Text] [Related]
14. PTX3, A prototypical long pentraxin, is an early indicator of acute myocardial infarction in humans.
Peri G; Introna M; Corradi D; Iacuitti G; Signorini S; Avanzini F; Pizzetti F; Maggioni AP; Moccetti T; Metra M; Cas LD; Ghezzi P; Sipe JD; Re G; Olivetti G; Mantovani A; Latini R
Circulation; 2000 Aug; 102(6):636-41. PubMed ID: 10931803
[TBL] [Abstract][Full Text] [Related]
15. Vascular pentraxin 3 controls arterial thrombosis by targeting collagen and fibrinogen induced platelets aggregation.
Bonacina F; Barbieri SS; Cutuli L; Amadio P; Doni A; Sironi M; Tartari S; Mantovani A; Bottazzi B; Garlanda C; Tremoli E; Catapano AL; Norata GD
Biochim Biophys Acta; 2016 Jun; 1862(6):1182-90. PubMed ID: 26976330
[TBL] [Abstract][Full Text] [Related]
16. Cardio-protective effects of pentraxin 3 produced from bone marrow-derived cells against ischemia/reperfusion injury.
Shimizu T; Suzuki S; Sato A; Nakamura Y; Ikeda K; Saitoh S; Misaka S; Shishido T; Kubota I; Takeishi Y
J Mol Cell Cardiol; 2015 Dec; 89(Pt B):306-13. PubMed ID: 26470821
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory status in patients with chronic renal failure: the role of PTX3 and pro-inflammatory cytokines.
Malaponte G; Libra M; Bevelacqua Y; Merito P; Fatuzzo P; Rapisarda F; Cristina M; Naselli G; Stivala F; Mazzarino MC; Castellino P
Int J Mol Med; 2007 Oct; 20(4):471-81. PubMed ID: 17786277
[TBL] [Abstract][Full Text] [Related]
18. Pentraxin3 and high-sensitive C-reactive protein are independent inflammatory markers released during high-intensity exercise.
Nakajima T; Kurano M; Hasegawa T; Takano H; Iida H; Yasuda T; Fukuda T; Madarame H; Uno K; Meguro K; Shiga T; Sagara M; Nagata T; Maemura K; Hirata Y; Yamasoba T; Nagai R
Eur J Appl Physiol; 2010 Nov; 110(5):905-13. PubMed ID: 20640440
[TBL] [Abstract][Full Text] [Related]
19. Equine platelets inhibit E. coli growth and can be activated by bacterial lipopolysaccharide and lipoteichoic acid although superoxide anion production does not occur and platelet activation is not associated with enhanced production by neutrophils.
Aktan I; Dunkel B; Cunningham FM
Vet Immunol Immunopathol; 2013 Apr; 152(3-4):209-17. PubMed ID: 23332730
[TBL] [Abstract][Full Text] [Related]
20. Neutrophils phagocytose activated platelets in vivo: a phosphatidylserine, P-selectin, and {beta}2 integrin-dependent cell clearance program.
Maugeri N; Rovere-Querini P; Evangelista V; Covino C; Capobianco A; Bertilaccio MT; Piccoli A; Totani L; Cianflone D; Maseri A; Manfredi AA
Blood; 2009 May; 113(21):5254-65. PubMed ID: 19264679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
